FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280497854> ?p ?o ?g. }

• W4280497854 endingPage "5014" @default.
• W4280497854 startingPage "5014" @default.
• W4280497854 abstract "Repetitive quarantines and social restrictions during the coronavirus disease 2019 (COVID-19) pandemic have negatively affected the population health in general, and the control of hypertension (HTN) in particular. Aim . To evaluate the control of HTN in the Russian population during the COVID-19 period based on the results of screening for HTN May Measurement Month 2021 (MMM2021). Material and methods . During May-August 2021, 2491 participants from 11 Russian regions took part in the screening. Participation was voluntary without restrictions on sex. All participants were over 18 years of age. During the screening, blood pressure (BP) was measured three times using automatic and mechanical BP monitors. In addition, a questionnaire was filled out on behavioral risk factors, comorbidities and therapy. HTN was diagnosed with systolic BP ≥140 mmHg and/ or diastolic blood pressure ≥90 mmHg and/or taking antihypertensive therapy. The questionnaire included questions about prior COVID-19, vaccinations and their impact on the intake of antihypertensive drugs. Results . The analysis included data from 2461 respondents aged 18 to 92, of which 963 were men (39,1%). The proportion of hypertensive patients was 41,0%, while among them 59,0% took antihypertensives and 30,9% were effectively treated. In comparison with pre-pandemic period according to MMM2018-2019, the higher proportion of HTN patients in the Russian sample was revealed during MMM2021 (41,0% vs 31,3%, p<0,001) with a comparable proportion of patients receiving antihypertensive therapy (60,7% vs 59,0%, p=0,05) and treatment efficacy (28,7% vs 30,9%, p=0,36). Monotherapy was received in 44,7% of cases, while dual and triple combination therapy — in 30,9% and 14,1%, respectively. The majority of respondents (~90%) did not adjust their antihypertensive therapy during the COVID-19 pandemic. Conclusion . According to HTN screening in Russia, there is persistent ineffective control of HTN, which may be due to both the worsening pattern of behavioral risk factors, limited access to healthcare during COVID-19, and the inertia of physicians and low adherence of patients due to the asymptomatic HTN course in the majority." @default.
• W4280497854 created "2022-05-22" @default.
• W4280497854 creator A5002446605 @default.
• W4280497854 creator A5007900114 @default.
• W4280497854 creator A5009929615 @default.
• W4280497854 creator A5011984119 @default.
• W4280497854 creator A5015304347 @default.
• W4280497854 creator A5018577298 @default.
• W4280497854 creator A5023199670 @default.
• W4280497854 creator A5027698843 @default.
• W4280497854 creator A5029961821 @default.
• W4280497854 creator A5030417044 @default.
• W4280497854 creator A5033554113 @default.
• W4280497854 creator A5033870663 @default.
• W4280497854 creator A5034393791 @default.
• W4280497854 creator A5039449330 @default.
• W4280497854 creator A5045302326 @default.
• W4280497854 creator A5046714862 @default.
• W4280497854 creator A5053305973 @default.
• W4280497854 creator A5053782111 @default.
• W4280497854 creator A5058096768 @default.
• W4280497854 creator A5059163620 @default.
• W4280497854 creator A5059608687 @default.
• W4280497854 creator A5061312362 @default.
• W4280497854 creator A5061515877 @default.
• W4280497854 creator A5064482549 @default.
• W4280497854 creator A5065510549 @default.
• W4280497854 creator A5071876358 @default.
• W4280497854 creator A5075365394 @default.
• W4280497854 creator A5076055655 @default.
• W4280497854 creator A5076368719 @default.
• W4280497854 creator A5079211402 @default.
• W4280497854 creator A5080227496 @default.
• W4280497854 creator A5083654457 @default.
• W4280497854 creator A5088833519 @default.
• W4280497854 creator A5001344042 @default.
• W4280497854 date "2022-04-15" @default.
• W4280497854 modified "2023-09-27" @default.
• W4280497854 title "Hypertension control during the COVID-19 pandemic: results of the MMM2021 in Russia" @default.
• W4280497854 cites W2804882919 @default.
• W4280497854 cites W2942083349 @default.
• W4280497854 cites W2971698813 @default.
• W4280497854 cites W3015897891 @default.
• W4280497854 cites W3025549141 @default.
• W4280497854 cites W3111309004 @default.
• W4280497854 cites W3120680547 @default.
• W4280497854 cites W3149115611 @default.
• W4280497854 cites W3164766143 @default.
• W4280497854 cites W3193823764 @default.
• W4280497854 cites W3199175385 @default.
• W4280497854 cites W3203310594 @default.
• W4280497854 cites W3209995045 @default.
• W4280497854 cites W3217367282 @default.
• W4280497854 cites W4200577257 @default.
• W4280497854 cites W4211015804 @default.
• W4280497854 cites W4212775694 @default.
• W4280497854 doi "https://doi.org/10.15829/29/1560-4071-2022-5014" @default.
• W4280497854 hasPublicationYear "2022" @default.
• W4280497854 type Work @default.
• W4280497854 citedByCount "1" @default.
• W4280497854 countsByYear W42804978542023 @default.
• W4280497854 crossrefType "journal-article" @default.
• W4280497854 hasAuthorship W4280497854A5001344042 @default.
• W4280497854 hasAuthorship W4280497854A5002446605 @default.
• W4280497854 hasAuthorship W4280497854A5007900114 @default.
• W4280497854 hasAuthorship W4280497854A5009929615 @default.
• W4280497854 hasAuthorship W4280497854A5011984119 @default.
• W4280497854 hasAuthorship W4280497854A5015304347 @default.
• W4280497854 hasAuthorship W4280497854A5018577298 @default.
• W4280497854 hasAuthorship W4280497854A5023199670 @default.
• W4280497854 hasAuthorship W4280497854A5027698843 @default.
• W4280497854 hasAuthorship W4280497854A5029961821 @default.
• W4280497854 hasAuthorship W4280497854A5030417044 @default.
• W4280497854 hasAuthorship W4280497854A5033554113 @default.
• W4280497854 hasAuthorship W4280497854A5033870663 @default.
• W4280497854 hasAuthorship W4280497854A5034393791 @default.
• W4280497854 hasAuthorship W4280497854A5039449330 @default.
• W4280497854 hasAuthorship W4280497854A5045302326 @default.
• W4280497854 hasAuthorship W4280497854A5046714862 @default.
• W4280497854 hasAuthorship W4280497854A5053305973 @default.
• W4280497854 hasAuthorship W4280497854A5053782111 @default.
• W4280497854 hasAuthorship W4280497854A5058096768 @default.
• W4280497854 hasAuthorship W4280497854A5059163620 @default.
• W4280497854 hasAuthorship W4280497854A5059608687 @default.
• W4280497854 hasAuthorship W4280497854A5061312362 @default.
• W4280497854 hasAuthorship W4280497854A5061515877 @default.
• W4280497854 hasAuthorship W4280497854A5064482549 @default.
• W4280497854 hasAuthorship W4280497854A5065510549 @default.
• W4280497854 hasAuthorship W4280497854A5071876358 @default.
• W4280497854 hasAuthorship W4280497854A5075365394 @default.
• W4280497854 hasAuthorship W4280497854A5076055655 @default.
• W4280497854 hasAuthorship W4280497854A5076368719 @default.
• W4280497854 hasAuthorship W4280497854A5079211402 @default.
• W4280497854 hasAuthorship W4280497854A5080227496 @default.
• W4280497854 hasAuthorship W4280497854A5083654457 @default.
• W4280497854 hasAuthorship W4280497854A5088833519 @default.
• W4280497854 hasBestOaLocation W42804978541 @default.
• W4280497854 hasConcept C126322002 @default.

• next